Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods

Journal of Microbiology, Immunology and Infection

Volumn 33, Issue 4, 2000, Pages 258-262

  Wang, J T ^a   Chang, S C ^a   Chen, Y C ^a   Luh, K T ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Citrobacter freundii; Minimum inhibitory concentration; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFPIROME; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CITROBACTER FREUNDII; IMMUNE DEFICIENCY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

CITROBACTER FREUNDII; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

EID: 0034521425     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Citrobacter infections in humans: Experience at the Seattle Veterans Administration Medical Center and a review of the literature
2. Bacteria producing trimethylene glycol
3. Clinical significance of Citrobacter isolates
4. Citrobacter species
5. Major trends in the microbial etiology of nosocomial infection
6. Reviews of Citrobacter bacteremia in cancer patients over a sixteen-year period
7. Antimicrobial susceptibility patterns (antibiograms) as an aid in differentiating Citrobacter species
8. Development of resistance to cephalosporins in clinical strains of Citrobacter spp.
9. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms
10. Cloning and characterization of an aminoglycoside 6'-N-acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile
11. Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii
12. Clinical isolate of Citrobacter freundii highly resistant to new quinolones
13. Bacteremia due to Citrobacter species: Significance of primary intra-abdominal infection
14. Enterobacteriaceae: Introduction and identification
15. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR 810, a fourth-generation cephalosporin, in clinical microbiology laboratories
16. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs
17. Cefepime: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
18. Cefpirome: A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia
19. The most frequent aminoglycoside resistance mechanisms - Changes with time and geographic area: A reflection of aminoglycoside usage patterns?
20. Bacterial resistance to aminoglycoside antibiotics
21. Bacterial resistance: A worldwide problem